Clinical Trial Update: A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing paclitaxel-based regimens with radiotherapy in locally advanced esophageal squamous cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Radiotherapy
• paclitaxel-based regimens (paclitaxel)

Snippet

Sponsor: Fudan University | Conditions: Stage III Esophageal Squamous Cell Carcinoma | Phase 3 | Status: COMPLETED